NCT00950066 - Irbesartan and Amlodipine Combination in Controlling Blood Pressure | Biotech Hunter

Enrollment

270

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Hypertension

Interventions

DRUG

IRBESARTAN (SR47436)

Oral administration of Irbesartan 150mg or 300mg once a day

DRUG

Amlodipine

Oral administration of Amlodipine 5mg once a day

DRUG

Irbesartan / Amlodipine

Oral administration of Irbesartan 150 mg / Amlodipine 5mg or Irbesartan 300mg / Amlodipine 5mg once a day

DRUG

Placebo

Oral administration of a placebo once a day

Trial Locations (4)

Sanofi-Aventis Administrative Office, Mumbai

Sanofi-Aventis Administrative Office, Makati City

Sanofi-Aventis Administrative Office, Seoul

Sanofi-Aventis Administrative Office, Taipei